Form of Viagara Found in Supplement
The product Joyful Slim Herb Supplement, marketed as a natural herb for weight loss was recalled by the Food and Drug Administration (FDA) due to an undeclared drug ingredient.
FDA analysis of the herb supplement found it to contain the drug desmethyl sibutramine. Many people will recognize sibutramine as the prescription weight-loss drug Meridia.
The FDA approved the drug desmethyl sibutramine for use as an appetite suppressant for weight loss, but is known to substantially increase blood pressure and pulse rate in some patients. It also may pose a significant risk for patients with a history of congestive heart failure, arrhythmias, coronary artery disease or stroke.
J&H Besta Corp., the makers of Slim-30, announced a voluntary, nationwide recall of the product on July 16 because it contains weight-loss ingredients that have not been approved for the product.
The recalled Joyful Slim pills are sold in plastic bottles containing 30 capsules per bottle and bears UPC 8 97966 00200 7. The affected lot/code being recalled is 101408. The product was sold to distributors and retail stores nationwide and via internet sales.
In a statement issued by J&H Besta Corp, “The company has discontinued distribution of Joyful Slim, and sincerely regrets any inconvenience to our customers.”
Consumers should not consume the Joyful Slim Herb Supplement and should return it immediately to the place of purchase for a full refund. Consumers with questions should contact Jason Wang at 877-547-5468, Monday through Friday, 10:00 am to 5:30 pm, EDT
Also recalled this month by the FDA was Good Health's Vialipro, currently being marketed as an “all natural” dietary supplement for male enhancement.
This product manufactured by Good Health, Inc., Canutillo, TX, is currently being sold as a dietary supplement throughout the U.S.
Sold mainly via the internet, the product promises:
“Vialipro is all natural and will help increase the libido by effectively removing blockages in the arteries to promote enhanced blood flow to the penis, without the worry of damaging side effects.”
The problem is, neither of these "promises" is true. The FDA found Vialipro to contain sulfoaildenafil, which is not “all natural”, but is a cousin of sildenafil, which is best known as Viagra a prescription medication for the treatment of erectile dysfunction (ED).
Viagra comes with a plethora of warnings and side effects including headache, facial flushing, upset stomach, blurred vision, sensitivity to light, decrease or loss of hearing and sudden loss of vision.
As stated in the FDA Recall Alert, “The undeclared ingredient may pose a threat to the consumer because the interaction of the analogue with some prescription drugs (such as nitroglycerin) may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take other prescription drugs. Erectile Dysfunction is a common problem in men with these conditions, and consumers may seek these types of products to enhance sexual performance.”
A spokesperson for Good Health, Inc., stated, “Good Health, Inc. takes this recall very seriously and is committed to the diligent work required to ensuring its products remain free of any potentially unapproved chemicals. We take the utmost pride in our product quality control and have the highest regard for our customer's health. “
Furthermore, “ It is the position of Good Health, Inc. that we did not in any way knowingly or intentionally violate the law with regard to the distribution of these products."
Consumers who have purchased Vialipro are urged to discontinue its use and return it to Good Health, Inc. Customers can call Good Health, Inc. at 1 (866) 607-0338 Monday through Friday from 9:00 am - 5:00 pm MST for instructions on the return and refund process.
The drugs Meridian and Viagra, while approved by the FDA, are intended to be sold as prescription drugs, thereby assuring physicians and patients have discussed the benefits, as well as the risks, of consuming these drugs, and have evaluated the overall health and safety of the patient.
Laura Lamp King